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Biochemistry
Effect of Fv-1 gene product on proviral DNA formation and
integration in cells infected with murine leukemia viruses
(N-tropic murine leukemia virus/B-tropic murine leukemia virus/provirus)
PAUL JOLICOEUR* AND DAVID BALTIMORE
Department of Biology and Center for Cancer Research, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Mass. 02139
Contributed by David Baltimore, April 12,1976
ABSiltRA(A' The amounts of unintegrated miurme leukemia
virus-specific DNA detected by molecular hybridization in ex-
tracts of IFv-ln/n (strains NIH/3T3, SIM) or Fv-lb/b (strains
JLS-V9, SIM.R) mouse cells after infection with N- or B-tropic
viruses were found to be the same in both permissive and re-
sistant cells. Therefore, formation of DNA products from the
viral RNA template does not appear to be grossly affected by
the Fv-1 gene product.
Integration of virus-specific DNA into chromosomal cellular
DNA was assayed byhybridization of radioactive comple-
mentaryDNA to DNA from infected cells. With either NIH/313
or SIM.R cells infected with N- or B-tropic viruses, integration
of proviral DNA could be detected in permissive cells but not
in nonpermissive cells. The FV-1 gene product therefore appears
to prevent integration of proviral DNA.
The Fv-1 gene of the mouse controls host range susceptibility
of murine cells to strains of murine leukemia virus (MuLV) (1).
The Fv-lb and Fv-ln alleles are dominant alleles interfering
with replication of N-tropic and B-tropic viruses, respectively
(2,3). So, Fv-ln/n cells are. permissive to N-tropic viruses
and resistant to B-tropic viruses; and F*1b/b cells are permissive
to B-tropic viruses and resistant to N-tropic viruses.
Fv-1 gene restriction is a post-penetration event because viral
pseudotypes, in which coats of N- or B-tropic MuLV surround
the vesicular stomatitis virus genome, are not restricted by
murine FvjOn/n or Fv-1 b/b cells (4, 5). In previous work (6), we
have shown that the late events of the virus cycle, namely, virus
production and accumulation of virus-specific RNA, are
blocked in Fv-1 -resistant cells infected with N- or B-tropic vi-
ruses. These results suggest that the Fv-1 gene product in
nonpermissive cells blocks eitlier the transcription of integrated
proviral DNA or the integration or synthesis of proviral
DNA.
To distinguish among these possibilities, we have studied the
early events of the virus cycle. We report here that accumula-
tion of proviral DNA by the reverse transcription process is not
affected by the Fv-1 gene product, but integration of proviral
DNA into cellular DNA does not occur in Fv-1 -resistant cells.
MATERIALS AND METHODS
Cells and Viruses. The origins of JLS-V9 cells (7) and of
NIH/3T3, BALB/3T3, SIM, and SIM.R cells (8) have been
given. The cloiied N-tropic virus (N-CI-35) and B-tropic virus
(B-Cl-ll) have been described (8). The virus titers of stocks were
1-5 X 106 plaque-forming units/ml as determined on permis-
Abbreviations: MuLV, murine leukemia virus; cDNA, DNA comple-
mentary to the MuLV genome, made by reverse transcription in vitro,
Cot, initial concentration of DNA (moles of nucleotide/liter) X time
(sec).
* Present address: Institut de Recherches Cliniques de Montreal, 110
Ouest Avenue des Pins, Montreal, Canada.
sive NIH/3T3 or BALB/8T3 cells by the XC plaque assay
(9).
Virus Infection and Infective Center Assay. Subconfluent
cells, grown in 257mm roller bottles, were infected with 10-15
ml of virus suspension in the presence of 8 Mg/ml of Polybrene
(10) for 10-12 hr. Cells were then fed with 40 ml of medium
and incubated. To determine the percentage of infected cells,
5-10 hr after infection, cells from each group were dispersed
in 0.5% trypsin and an infective center assay was performed
as previously described for JLS-V9 (7) or for NIH/3T3, SIM,
and SIM.R cells (8).
Synthesis of Viral [3H~cDNA. 3H-Labeled DNA comple-
mentary to B-Cl-il virus RNA was prepared by incubating
banded virions in the presence of 0.05 M Tris-HCl, 0.02 M di-
thiothreitol, 0.06 M Natl, 6 mM Mg acetate, 4 mM each of
dATP, dGTP, and dCTP, 0.01% Nonidet P40 (Shell Oil Co.),
40 Mg/ml of actinomycin D (a gift from Merck, Sharp and
Dohme), and 20 MM [3H]dTTP (48 Ci/mmol) (New England
Nuclear Corp.). After incubation, the reaction mixture was
deproteinized and processed as described (11). This [3H]cDNA
had a specific activity of 2 X 107 cpm/ g and a resistance to Si
nuclease of 2.5%. At saturation, 80% of this probe hybridized
to homologous viral RNA and 73% to DNA from B-Cl-li
chronically infected cells.
Extraction of Unintegrated Viral DNA. The technique for
quantitative detection of unintegrated viral DNA in infected
cells was modified from Gianni et al. (7). Cells were extracted
by the Hirt procedure (12) 10-12 hr after infection, The-Hirt
supernatant was extracted three times with CHC1-4% isoamyl
alcohol and precipitated with two volumes of ethanol at -200.
Nucleic acids were then resuspended in 0.3M NaOH, 25 mM
EDTA, incubated for 18 hr at 370, neutralized, and ethanol
precipitated. The RNA-free nucleic acids were resuspended
in 1 ml of H20 and passed through a Sephadex G-50 column
(1.5 cm X 35 cm) equilibrated with triethylammonium bicar-
bonate buffer (pH 7.0). The column elution pattern was de-
termined by absorbance at 260 nm and the fractions comprising
the front peak (free of mononucleotides) were pooled. This
fraction contained mitochondrial DNA plus sheared, low-
molecular-weight, nuclear DNA and was assayed for proviral
DNA. The amount of DNA present in the pooled fractions was
determined by absorbance at 260 nm. DNA extracts were re-
suspended at the same concentration for hybridization. Vari-
ations in the total Amo recovered from equal numbers of in-
fected cells were less than 40%o.
To fragment the DNA by acid depurination (13), it was ly-
ophilized, resuspended in 0.1 M sodium acetate (pH 4.3) for 20
min at 670, boiled for 5 min in 0.3 M NaOH, and then precip-
itated by ethanol in the presence of 100 Mig of yeast tRNA as
carrier. For hybridization, the DNA was resuspended in 0.6 M
sodium phosphate buffer (pH 6.8), 0.1% sodium dodecyl sulfate,
5 mM EDT-A.
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Preparation of Cellular DNA for Detection of Integrated
Proviral DNA. Cells were extracted by the Hirt procedure (12)
34-48 hr after infection and the Hirt pellet, containing the
high-molecular-weight DNA, was gently resuspended in 0.01
M Tris-HCI (pH 7.5), 0.01 M EDTA. The solution was treated
with Pronase (1 mg/ml) at 370 for 2 hr, brought to 0.5% sodium
dodecyl sulfate, extracted twice with phenol and once with
CHCL3-4% isoamyl alcohol, and ethanol precipitated. TheDNA
was resuspended in 0.1 X standard saline citrate (1 X standard
saline citrate = 0.15 M NaCl, 0.015 sodium citrate), brought
to 0.3 M NaOH, incubated for 18 hr at 370, neutralized, and
dialyzed extensively against 0.2M NaCl in 0.1 X standard saline
citrate, and then against 0.1 X standard saline citrate. TheDNA
solution was then carried through the network-forming pro-
cedure as described by Varmus et al. (14). Briefly, the DNA
solution was denatured at 1000 for 5 min, cooled on ice, brought
to 0.6 M NaCl, and hybridized at 670 to a Cot [initial concen-
tration of DNA (moles of nucleotide/liter) X time (sec)] of 1 to
5. The solution was allowed to stand on ice for 2-3 hr and was
then centrifuged at 25,000 rpm for 30 min in the Spinco 30
rotor. From 65% to 80% of the DNA was recovered in the pellet
(network pellet DNA). It was resuspended in 0.1 X standard
saline citrate and broken to 350-450 nucleotide-long fragments
by acid depurination (13) as described above, except that a
45-min acid treatment was used. For hybridization, DNA was
resuspended in 0.01 M Tris-HCl (pH 7.5), 0.72 M NaCi, 0.05%
sodium dodecyl sulfate, and 5 mM EDTA. The concentration
was determined by absorbance at 260 nm (25 AW0 = 1 mg/ml).
Hybridization. For detection of unintegrated, virus-specific
DNA, different concentrations of Hirt supernatant DNA ex-
tracts were mixed in 0.02 ml reaction volumes with [3H]cDNA
(400-600 cpm). Mixtures were boiled for 5 min, cooled on ice,
and incubated at 670 for 60 hr. The extent of hybridization was
monitored by hydroxylapatite chromatography (15).
To assay the hybridization of network pellet DNA, it was
mixed in 0.05 ml reaction volumes with [3H]cDNA (600-90
cpm) and sealed in capillaries for hybridization. The mixtures
were boiled for 5 min, cooled on ice, and incubated at 67°. At
different times, capillaries were transferred at 40 to stop the
annealing reaction. Hybridization of [3H]cDNA to virus-specific
DNA was measured by Si nuclease resistance, as described (11),
and was plotted versus the input DNA concentration (Co)
multiplied by the time of hybridization (t) (16). The Cot values
have been corrected to an equivalent Cot at a Na+ concentration
of 0.18 M (17).
RESULTS
Effect of Fv-1 alleles on viral DNA production
Soon after they enter cells, the RNA genomes of murine (7,
18-20) and avian (21, 22) leukemia or sarcoma viruses are
copied into linear and closed-circular double-stranded DNA
molecules. It is not known at present which of these molecules
is the precursor of the integrated DNA found later in the in-
fection.
To determine whether the Fv-1 gene product affects this
reverse transcription process, we have measured the amount
of virus-specific DNA made early after infection of Fv-1-sen-
sitive and resistant cells. In these experiments, infection was
allowed to proceed for 10-12 hr before viral DNA was assayed
because Gianni et al. (7) showed that the maximal amount of
unintegrated proviral DNA is found at this time.
To assay for free viral DNA, cells were extracted by the Hirt
procedure (12), a technique that efficiently separates low-
molecular-weight DNA (supernatant) from high-molecular-
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FIG. 1. Detection of unintegrated proviral DNA in JLS-V9 cells
infected with N- and B-tropic MuLV. Subconfluent JLS-V9 cells (5
X 108 cells) were divided into four groups. Two groups were infected
with N-Cl-35 or B-Cl-11 viruses at a multiplicity of approximately
2 plaque-forming units per cell and a third group was infected with
the same B-Cl-11 virus preparation diluted 50-fold to a multiplicity
of 0.04. The fourth group was not infected and served as a control.
Infection was done with 10 ml of virus suspension per roller bottle
containing 8 ,g/ml of Polybrene for 12 hr at 370. Six hours after the
beginning of infection, one roller bottle of each group was trypsinized
to determine the percentage of infected cells by infective center assay.
After infection, the medium was decanted and the cells were washed
with 0.01 M Tris-HCl (pH 7.5) and extracted by the Hirt procedure.
The DNA prepared from the Hirt supernatant, as described in Ma-
terials and Methods, was hybridized at different concentrations to
a fixed amount of [3H]cDNA for 60 hr. Hybrid formation was assayed
by hydroxylapatite.chromatography. Hirt supernatant DNA from:
A-A, uninfected cells; o O-, cells infected with B-Cl-11 virus
(multiplicity of infection = 2); *-*, cells infected with N-Cl-35
virus; --- -0, cells infected with B-Cl-11 virus (multiplicity of in-
fection = 0.04).
weight DNA (pellet). Unintegrated virus-specific DNA was
quantitated in the Hirt supernatant DNA by assaying its an-
nealing to a B-tropic MuLV [3HJcDNA using hydroxylapatite
chromatography to score the hybrids. B-tropic MuLV cDNA
could be used to detect both N-tropic and B-tropic virus-specific
DNA, because previous experiments (6, 23) have shown that
the two MuLV genomes are virtually indistinguishable by hy-
bridization.
In the initial experiment, JLS-V9 cells-a line derived from
BALB/c mice (24) and therefore Fv-1b/b-were infected with
a multiplicity of 2 plaque-forming units per cell of either N-
tropic or B-tropic MuLV. At 12 hr after infection, virus-specific
DNA in the Hirt supernatant of infected and uninfected cells
was assayed by incubating increasing amounts of the DNA with
a fixed amount of [3H]cDNA (Fig. 1). Although some virus-
specific DNA was evident in the extracts of uninfected cells-
presumably resulting from endogenous virus-related sequences
in low-molecular-weight fragments of nuclear DNA-much
more virus-specific DNA was found in the infected cells. No
difference in viral DNA content was evident between the cells
infected by N-tropic or B-tropic MuLV. When the cells were
infected with B-tropic MuLV at a multiplicity of 0.04
plaque-forming units per cell, less viral DNA was evident (Fig.
1), indicating that the assay is sensitive to a 50-fold difference
of infecting genomes.
In this experiment 80% and 5% of the cells infected with the
B-tropic virus at multiplicities of 2 and 0.04, respectively, scored
as infective centers while 0.7% of the N-tropic MuLV-infected
cells scored as infective centers. These values are consistent with
our earlier observations on BALB/3T3 cells (8). It is evident
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FIG. 2. Detection of unintegrated proviral DNA in NIH/3T3 cells
infected with N- and B-tropic MuLV. Subconfluent NIH/3T3 cells
(1.8 X i00 cells) were divided into three groups. Two groups were in-
fected with N-CI-35 or B-Cl-li viruses at a multiplicity of 0.8 and a
third group was not infected. Infection was done for 12 hr and the
DNA was extracted from the Hirt~supernatant and prepared for hy-
bridization as described in the legend to Fig. 1. Hirtsupernatant DNA
from: A- ,uniinfected cells; 0- ,cells infected with N-CI-35
virus; 0----0, cells infected with B-Cl-li virus.
that, in spite of the 100-fold restriction of the replication of the
N-tropic MuLV by the Fvlb allele, there was no restriction Of
viral DNA accumulation.
To determine whether the Fv-ln allele also allows reverse
transcription by a restricted MuLV, NIH/3T3 cells (Fv-1n/n)
were infected with N-tropic or B-tropic MuLV. As with the
BALB/c cells, the amounts of viral DNA formed in the two
cases were not distinguishable (Fig. 2), but infective center
assays showed that 35% of the cells were infected with the N-
tropic virus while only 0.6% were infected by the B-tropic virus.
To extend these observations, lines derived from SIM (Fv-
ln/n) and SIM.R (Fv~lb/b) mice were used. These mice are
congenic except for their Fv-1 regions (25) and so provide the
best strains with which to assay effects of the Fv-1 alleles. For
both the SIM and SIM.R lines, viral DNA concentrations in the
Hirt supernatants were the same whether the cells were infected
by B-tropic or N-tropic MuLV (Fig. 3). For the SIM cells, as
expected for Fv-1n/n cells, 60% were infected by N-tropic virus
and 1% by B-tropic virus; for the SIM.R cells, as expected for
FvI1b/b cells, 83% were infected by B-tropic virus and 1.2% by
N-tropic virus.
Thus, in four different cell lines, no effect of either Fv-1 allele
could be found on the early accumulation of virus-specific DNA
in cells that restricted the overall replication of the virus.
Effect of Fv-1 alleles on integration
After synthesis of viral DNA in cells infected by avian leukemia
or sarcoma viruses, integration of'the new DNA sequences into
host cell DNA can be demonstrated (14, 21, 22, 26-29). To
determine whether integration of MuLV-specific DNA into
cellular DNA can be demonstrated, and to study integration
of proviral DNA in Fv-1-resistant cells, high-molecular-weight
chromosomal DNA from infected cells was assayed for its
content of virus-specific sequences.
To assure that the viral DNA sequences under study were
integrated with high-molecular-weight cellular DNA, two
techniques were employed serially. The cell DNA was first
precipitated by the Hirt procedure (12) to purify mainly
high-molecular-weight DNA, and this DNA was then dena-
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FIG. 3. Detection of unintegrated proviral DNA in congenic SIM
and SIM.R cells infected with N- and B-tropic MuLV. (A) Subcon-
fluent SIM.R cells (2.4 X 108 cells) were divided into three groups.
Two groups were infected with N-Cl-35 or B-Cl-11 viruses at a mul-
tiplicity of 2, and a third group was not infected and served as a con-
trol. Infection was done for 10 hr. (B) Two of three groups of sub-
confluent SIM cells (1.5 X 108 cells) were infected with N-Cl-35 or
B-Cl-il viruses at a multiplicity of 1.5 for 12 hr. The third group
served as a control. After infection the DNA was extracted from the
Hirt supernatant and prepared for hybridization as described in the
legend to Fig. 1. Hirt supernatant DNA from: A A, uninfected
cells; 0 0, cells infected with N-Cl-35 virus; 0 O. cells in-
fected with B-Cl-11 virus.
tured and renatured briefly to allow network formation by
reannealing of the highly reiterated cellular DNA sequences
(14). The network DNA was then collected, broken, denatured,
and annealed in a greater than 2 X 106-fold excess to [3H]cDNA
for various lengths of- time to detect virus-specific DNA se-
quences.
A B-tropic cDNA probe will hybridize extensively to most
uninfected murine cell DNA (23,30). With cellular DNA from
some mouse strains, however, the reaction reaches a plateau
value before all of the available cDNA sequences have been
annealed, because part of the cDNA is not represented in the
virus-related sequences of the cell (30). In such cells, the ac-
quisition of new sequences can be detected after infection. We
have chosen two such murine lines, NIH/3T3 and SIM.R cells,
and have attempted to detect the addition of new sequences
following infection by N-tropic or B-tropic MuLV. We have
assayed for newly integrated DNA at 35-48 hr after infection
because, at that time, susceptible cells have started making viral
RNA-an indication that integration has occurred-but they
have made little progeny virus, thus minimizing the chance for
secondary infection (6).
When SIM.R cells (Fv-lb/b) were infected with B-tropic
MuLV, the acquisition of new viral DNA sequences in the cell
DNA was evidenced by an increased level of hybridization to
[3H]cDNA at high Cot values (Fig. 4). Uninfected cell DNA
protected 40% of the cDNA, while DNA from B-tropic
MuLV-infected cells protected at least 60% of the probe, and
a plateau was not achieved. Even at Cot values of 102-103, in-
fected cell DNA hybridized much more extensively to the probe
than did DNA from uninfected cells.
In contrast the high-molecular-weight DNA from N-tropic
MuLV-infected SIM.R cells hybridized only slightly more ex-
tensively than the DNA of the uninfected cells (Fig. 4). The
acquisition of some new sequences after N-tropic MuLV in-
fection is suggested by the final slope of the hybrdization curve
in Fig. 4. However, the hybridization curve for the N-tropic
MuLV-infected cell DNA is displaced on the Cot axis by at least
50-fold from the curve for the B-tropic MuLV-infected cell
Proc. Nati. Acad. Sci. USA 73 (1976)
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FIG. 4. Detection of integrated proviral DNA in SIM.R cells in-
fected with N- and B-tropic MuLV. Subconfluent SIM.R cells (2.5
X 108 cells) were divided into three groups. Two groups were infected
with N-CI-35 or B-Cl-u1 viruses at a multiplicity of 1 and a third group
was not infected. Infection was done for 10 hr, medium was added,
and cells were incubated for 48 hr. At the end of this period, the me-
dium was decanted and cells were washed and extracted by the Hirt
procedure. The DNA from the Hirt pellet was subjected to network
formation (Materials and Methods). The network pellet DNA was
prepared for hybridization with [3H]cDNA at a concentration of 4.4
mg/ml as described in Materials and Methods. Hybrid formation was
assayed by Si nuclease digestion. Network pelletDNA from
uninfected cells; 0-O, cells infected with B-Cl-li virus; *
-e,
cells infected with N-CI-35 virus.
DNA. In this experiment, 40% of the cells were infected by
-tropic virus and 0.3% by the N-tropic virus. Therefore the
pvlb allele restricts integration of viral DNA into cellular DNA
to about the same extent as it restricts infective center forma-
tion.
The converse experiment, carried out with NIH/3T3 cells
(Fv-1 n/n), gave the same result for the Fv-1 n allele. Infection
with N-tropic MuLV increased the maximum hybridization
level from 40% to 55%, while infection with B-tropic MuLV
resulted in at most a slight addition of new sequences (Fig. 5).
Infective center assays showed 82% infection with the N-tropic
virus, 1.8% infection with the B-tropic virus; the hybridization
curves suggest at least 50-fold fewer new sequences in the B-
tropic MuLV-infected cells compared to the N-tropic MuLV-
infected cells.
Comparable data have been obtained in five separate ex-
periments. We conclude that the Fv-1 locus acts to prevent
integration of newly made viral DNA, but does not prevent its
synthesis.
DISCUSSION
We previously showed that when a B-tropic or N-tropic MuLV
infects a cell that has an incompatible Fv-1 allele, the accu-
mulation of virus-specific RNA is reduced to the same extent
as the yield of virions (6). Those experiments placed the Fv-1
restriction at or prior to transcription. In the present work, we
have examined the infection cycle from the beginning.
Knowing that the Fv-i product acts after penetration of the
viral genome into the cell (4, 5), we first measured viral DNA
accumulation and found it to be insensitive to the Fv-1 gene
product. Integration of new viral DNA into cells with an in-
compatible Fv-1 allele, however, did not occur. We conclude
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FIG. 5. Detection of integrated proviral DNA in NIH/3T3 cells
infected with N- and B-tropic MuLV. Subconfluent NIH/3T3 cells
(4.6 X 108 cells) were divided into three groups. Two groups were in-
fected with N-CI-35 or B-Cl-11 viruses at a multiplicity of 2 and a third
group was not infected. Infection was for 11 hr, medium was added,
and cells were incubated for 34 hr. After incubation, network pellet
DNA was prepared and hybridized at a concentration of 9.0 mg/ml,
as described in the legend to Fig. 4. Network pellet DNA from:
^ a~, uninfected cells; --- -0, cells infected with B-Cl-li virus;
0, cells infected with N-CI-35 virus.
that the Fv-ln and Fv-lb alleles act at a step in the virus life-
cycle between the synthesis of viral DNA and its integration.
Most previous work on integration of proviral DNA into
cellular DNA after infection has involved avian viruses (14, 21,
22, 26-29). In the present work on murine viruses, we have had
to study integration in the face of two sources of artifacts: en-
dogenous virus-related sequences in the DNA of the uninfected
cell and unintegrated virus-specific DNA in the infected cell.
By choosing cells that do not contain endogenously all of the
sequences of the infecting virus (30), we have been able to
concentrate our attention on only the sequences of the incoming
virus. By using serially both Hirt extraction (12) and network
formation (14), we have attempted to minimize trapping of
unintegrated DNA with the high-molecular-weight cellular
DNA.
Exactly where might the Fv-1 gene product act? Unfortu-
nately, too little is known about the events of intracellular re-
verse transcription and integration to provide many hypotheses.
Two forms of viral DNA have been identified in infected cells:
closed-circular, duplex DNA and heterogeneous, linear DNA
that has full-length strands of DNA complementary to viral
RNA and smaller pieces of DNA of the same polarity as virion
RNA (7, 21, 31, 32). Assuming that the reverse transcription
process occurs in the cytoplasm, as it appears to with avian vi-
ruses (21), proviral DNA must be transported to the nucleus.
We know that both strands of proviral DNA are made in Fv-
1-incompatible cells because we used cDNA that detects the
second strand of DNA made in infected cells. Therefore, some
possible modes of action of the Fv-1 gene product are: (a)
prevention of circularization of proviral DNA if that is a nec-
essary step for integration; (b) interference with some other,
as yet unknown step in the maturation of viral DNA to the form
that integrates; (c) inhibition of transport of proviral DNA into
the nucleus; (d) direct inhibition of integration; or (e) cleavage
or degradation of proviral DNA, possibly by an enzyme anal-
ogous to a bacterial restriction endonuclease (33). We have no
way of choosing among these alternatives at present.
The possible models of Fv-1 action have been sharply re-
stricted by the experiments of Rein et al. (34) and Bassin et al.
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(35). Their experiments indicate that the viral structure sus-
ceptible to the Fv-1 product is one provided by MuLV to mu-
rine sarcoma virus. Furthermore, the Fv-1-sensitive structure
can be phenotypically mixed in the yield of MuLV from cells
co-infected with N-tropic and B-tropic virus. Such a structure
would probably be a protein. The only known virus-coded
protein that functions early in the MuLV growth cycle is the
reverse transcriptase and, because so much of the coding ca-
pacity of the genome has been assigned to known functions,
there may not be new viral proteins to discover (36). To rec-
oncile these facts with our observation that the bulk synthesis
of reverse-transcribed DNA occurs normally in Fv-1-resistant
cells, we must postulate a function for reverse transcriptase
beyond the manufacture of DNA. This function would be the
one specifically affected by products of Fv-1 alleles.
Sveda et al. (37), using different techniques, previously
suggested that the Fv-1 product does not prevent integration.
Using techniques similar to ours, they now find, in agreement
with our data, that integration does not occur during infection
of Fv-1-incompatible cells (38).
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